• Explore /
  • Poster
  • / TRUST-II: A global phase II study for taletrectinib in <em>ROS1</em> fusion–positive lung cancer and other solid tumors.

TRUST-II: A global phase II study for taletrectinib in ROS1 fusion–positive lung cancer and other solid tumors.

Abstract Poster

Authors

null

Misako Nagasaka

University of California Irvine School of Medicine and Chao Family Comprehensive Cancer Center, Orange, CA

Misako Nagasaka , Shunichi Sugawara , Chang-Min Choi , Tatsuro Okamoto , Noriko Yanagitani , Kaname Nosaki , Toshiaki Takahashi , Yutaka Fujiwara , Hidetoshi Hayashi , John Khoury , Jorge J. Nieva , A. Eli Gabayan , Luis E. Raez , Hongbin Chen , Anastasios Dimou , Nathan A. Pennell , Geoffrey Liu , Sai-Hong Ignatius Ou , Takashi Seto , Yuichiro Ohe

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Small Cell Lung Cancer

Clinical Trial Registration Number

NCT04919811

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS8601)

DOI

10.1200/JCO.2022.40.16_suppl.TPS8601

Abstract #

TPS8601

Poster Bd #

221b

Abstract Disclosures

Similar Posters

First Author: Salvatore Siena

First Author: Kyle Concannon

First Author: Wei Li

First Author: Atsushi Nakamura